Literature DB >> 29604408

Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.

Dipanwita Sadhukhan1, Gautami Das1, Arindam Biswas1, Soumitra Ghosh1, Shyamal K Das2, Kunal Ray3, Jharna Ray4.   

Abstract

BACKGROUND: Parkinson's disease (PD) is the second most common neurodegenerative disease and has a complex etiology. Single nucleotide polymorphisms in the 3'-untranslated region of Fibroblast growth factor 20 (FGF 20) have been reported to be associated with PD; however, the results are controversial. Although FGF20 enhances the survival of dopaminergic neurons, it may also result in PD susceptibility by altering alpha-synuclein expression.
MATERIALS AND METHODS: To identify and characterize genetic risk variants in FGF 20 in Eastern Indian PD patients, 2 SNPs of FGF 20 (rs1721100 and rs2720208) were genotyped in 336 PD cases and 313 ethnically matched controls by PCR-RFLP.
RESULTS: We observed statistically significant differences in genotypic and allelic frequencies of rs1721100 between PD cases and controls but not for rs12720208. Haplotype G-C showed a significant protective effect against PD. A functional assay revealed that the risk allele C at rs1721100 has little or no effect on relative luciferase activity from a reporter construct in the presence of miR-3189-3p, whereas allele G results in significant dose-dependent reduction.
CONCLUSION: Our results suggest that FGF 20 is a susceptibility gene for PD in Eastern Indians.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Association; Fibroblast growth factor 20; MiR-3189-3p; Parkinson’s disease; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2018        PMID: 29604408     DOI: 10.1016/j.neulet.2018.03.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.

Authors:  Prosenjit Pal; Tamal Sadhukhan; Subhadip Chakraborty; Sriparna Sadhukhan; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  Neuromolecular Med       Date:  2019-05-28       Impact factor: 3.843

2.  Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.

Authors:  Wei Quan; Jia Li; Li Liu; Qinghui Zhang; Yidan Qin; Xiaochen Pei; Jiajun Chen
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.830

3.  Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer.

Authors:  Cecilia Vittori; Duane Jeansonne; Hassan Yousefi; Celeste Faia; Zhen Lin; Krzysztof Reiss; Francesca Peruzzi
Journal:  Cancer Cell Int       Date:  2022-05-31       Impact factor: 6.429

4.  Association analysis of SYT11, FGF20, GCH1 rare variants in Parkinson's disease.

Authors:  Jia-Li Pu; Zhi-Hao Lin; Ran Zheng; Yi-Qun Yan; Nai-Jia Xue; Xin-Zhen Yin; Bao-Rong Zhang
Journal:  CNS Neurosci Ther       Date:  2021-10-21       Impact factor: 5.243

5.  Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes.

Authors:  Zaipul I Md Dom; Eiichiro Satake; Jan Skupien; Bozena Krolewski; Kristina O'Neil; Jill A Willency; Simon T Dillon; Jonathan M Wilson; Hiroki Kobayashi; Katsuhito Ihara; Towia A Libermann; Marlon Pragnell; Kevin L Duffin; Andrzej S Krolewski
Journal:  Sci Transl Med       Date:  2021-06-30       Impact factor: 19.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.